RVMD
Revolution Medicines, Inc.
Stock
$205.26+0.78 (+0.38%)Close Sep 30, 2026
| Stock-based compensation (TTM) | YoY | 5-year CAGR |
|---|---|---|
| $219M | +125.2% | 67.8% |
| Stock-based compensation (TTM) | $219M |
|---|---|
| YoY | +125.2% |
| 5-year CAGR | 67.8% |
Stock-based compensation
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $118M | +49.5% |
| 2024 | $79M | +28.2% |
| 2023 | $62M | +98.0% |
| 2022 | $31M | +50.5% |
| 2021 | $21M | +133.2% |
| 2020 | $8.9M | +181.1% |
| 2019 | $3.2M | +269.7% |
| 2018 | $855K | — |